CS
GEVA

Candriam SCA’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Candriam SCA’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-55,000
Closed -$5.37M – 687
2015
Q1 		$5.37M Buy
55,000
+15,000
+38% +$1.59M 0.11% 242
2014
Q4 		$3.71M Buy
+40,000
New +$3.16M 0.08% 284

Candriam SCA's GEVA Position: Q2 2015 in Review

Candriam SCA sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 55,000 shares — an estimated $5.37M sold.

Candriam SCA first reported a position in GEVA in Q4 2014 and held it in 2 quarters. The position peaked at $5.37M in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Candriam SCA reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Candriam SCA sold 55,000 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $5.37M.
  • Candriam SCA first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Candriam SCA's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $5.37M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Candriam SCA's 13F filing for Q2 2015, filed 29 Jul 2015.